These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18847563)

  • 21. [Introduction to vaccination against cervical cancer].
    de Melker HE; Conyn-van Spaendonck MA; Boot HJ; Coutinho RA
    Ned Tijdschr Geneeskd; 2009 Apr; 153(14):658-61. PubMed ID: 19425324
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluating the impact of human papillomavirus vaccines.
    Chang Y; Brewer NT; Rinas AC; Schmitt K; Smith JS
    Vaccine; 2009 Jul; 27(32):4355-62. PubMed ID: 19515467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
    Pitts M; Smith A; Croy S; Lyons A; Ryall R; Garland S; Wong ML; Hseon TE
    Vaccine; 2009 May; 27(22):2989-93. PubMed ID: 19428910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The path to eliminate cervical cancer in the world and the challenges of professional education.
    Bosch FX
    Vaccine; 2013 Dec; 31 Suppl 5():xi-xii. PubMed ID: 24331752
    [No Abstract]   [Full Text] [Related]  

  • 25. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean.
    Luciani S; Andrus JK
    Reprod Health Matters; 2008 Nov; 16(32):59-66. PubMed ID: 19027623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Human papilloma virus and cervical cancer].
    Berumen-Campos J
    Gac Med Mex; 2006; 142 Suppl 2():51-9. PubMed ID: 19031679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Policy debate over human papillomavirus vaccines.
    Richman S
    J Low Genit Tract Dis; 2009 Apr; 13(2):128. PubMed ID: 19387138
    [No Abstract]   [Full Text] [Related]  

  • 29. Cervical cancer: the second-generation vaccines move forward.
    Tuma RS
    J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing cervical cancer: pediatricians role.
    Choudhury P
    Indian Pediatr; 2009 Mar; 46(3):201-3. PubMed ID: 19346566
    [No Abstract]   [Full Text] [Related]  

  • 32. Integrating human papillomavirus vaccination in cervical cancer control programmes.
    Franco EL; Coutlée F; Ferenczy A
    Public Health Genomics; 2009; 12(5-6):352-61. PubMed ID: 19684447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Public health issues related to HPV vaccination.
    Hershey JH; Velez LF
    J Public Health Manag Pract; 2009; 15(5):384-92. PubMed ID: 19704306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus (HPV) vaccines: limited cross-protection against additional HPV types.
    Herrero R
    J Infect Dis; 2009 Apr; 199(7):919-22. PubMed ID: 19236278
    [No Abstract]   [Full Text] [Related]  

  • 35. Short version of the German evidence-based Guidelines for prophylactic vaccination against HPV-associated neoplasia.
    Pathirana D; Hillemanns P; Petry KU; Becker N; Brockmeyer NH; Erdmann R; Gissmann L; Grundhewer H; Ikenberg H; Kaufmann AM; Klusmann J; Kopp I; Pfister H; Rzany B; Schneede P; Schneider A; Smola S; Winter-Koch N; Wutzler P; Gross G
    Vaccine; 2009 Jul; 27(34):4551-9. PubMed ID: 19524337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The improbable plunge. What facts refute reasons to expect that the effectiveness of HPV vaccination programs to prevent cervical cancer could be low?
    Porta M
    Prev Med; 2009 May; 48(5):407-10. PubMed ID: 19450725
    [No Abstract]   [Full Text] [Related]  

  • 37. Q & A with the man who can stop cervical cancer in its tracks.
    Bloom S
    J Clin Invest; 2005 Oct; 115(10):2587-8. PubMed ID: 16200188
    [No Abstract]   [Full Text] [Related]  

  • 38. [Grounds for the inclusion of vaccination against cervical cancer within the National Immunisation Programme].
    de Kok IM; Habbema JD; Mourits MJ; Coebergh JW; van Leeuwen FE
    Ned Tijdschr Geneeskd; 2008 Nov; 152(48):2639-40; author reply 2640-1. PubMed ID: 19105259
    [No Abstract]   [Full Text] [Related]  

  • 39. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
    Hessel L
    Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of prophylactic human papillomavirus vaccines: recommendations and monitoring in the US.
    Dunne EF; Datta SD; E Markowitz L
    Cancer; 2008 Nov; 113(10 Suppl):2995-3003. PubMed ID: 18980283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.